Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:e9005-e9006
doi: 10.1161/01.CIR.0000030060.75191.0E
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SoRelle, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by SoRelle, R.

(Circulation. 2002;106:e9005.)
© 2002 American Heart Association, Inc.

Cardiovascular News

Ruth SoRelle, MPH

Circulation Newswriter


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The Genetic Factor

Genetic factors play a significant role in the quantity of coronary artery calcification (CAC) found by electron beam computed tomography, according to researchers from the Mayo Clinic in Rochester, Minn, the Windber Research Institute in Windber, Pa, and The University of Texas Health Science Center in Houston, in a report in this week’s issue of Circulation (Circulation. 2002;106:304–308).

In the study, led by Patricia A. Peyser, PhD, of the Department of Epidemiology at the University of Michigan in Ann Arbor, researchers noted that although CAC quantity predicts future coronary heart problems, the measurable risk factors explain <50% of the variability in coronary artery calcification. To determine the factors that contribute to CAC, they quantified the contributions of known risk factors and genetic influences on the calcification quantity found in 698 asymptomatic adults.

They adjusted their calculations for age, sex, fasting glucose, systolic blood pressure, years of smoking (by pack), and low-density lipoprotein cholesterol, and found that 41.8% of the residual variation in CAC quantity could be attributed to genetic factors. "Our findings suggest a substantial genetic component for subclinical coronary atherosclerosis variation as measured by CAC quantity," they concluded, "even after accounting for effects of genes acting through some measured atherosclerosis risk factors. Although the CAC quantity process has a complex pathogenesis that likely is influenced by the interaction of numerous environmental and genetic factors, the evidence for genetic effects suggests it should be possible to localize previously unknown genes that influence CAC on quantity."

How Much Can Statins Do?
A landmark study . . . [Full Text of this Article]